ePrints

Rivastigmine in the treatment of parkinsonian psychosis anti cognitive impairment: Preliminary findings from an open trial

Lookup NU author(s): Dr Anna Luce, Professor Ian McKeith

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. (C) 2001 Movement Disorder Society.

Publication metadata

Author(s): McKeith IG; Luce AK; Reading PJ

Publication type: Article

Publication status: Published

Journal: Movement Disorders

Year: 2001

Volume: 16

Issue: 6

Pages: 1171-1174

ISSN (print): 0885-3185

ISSN (electronic): 1531-8257

Publisher: John Wiley & Sons

URL: http://dx.doi.org/10.1002/mds.1204

DOI: 10.1002/mds.1204

Altmetrics

Share